Johnson & Johnson CEO Alex Gorsky emphasized his company’s commitment to developing technology for robotic-assisted surgery during the company’s 2019 fourth-quarter earnings call on 22 January.
J&J is late to the robotic-assisted surgery market, but the health-care giant has made a series of acquisitions in robotic-assisted...